Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 55.88
+2.32 (4.33%)
At close: Sep 2, 2026
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 7.46 billion as of September 2, 2026. Its market cap has increased by 22.33% in one year.
Market Cap
7.46B
Enterprise Value
5.81B
Revenue
453.39M
Ranking
n/a
PE Ratio
181.55
Stock Price
55.88
ChartMarket Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 7.46B, a decrease of -28.49%. That is a compound annual growth rate of -8.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 7.78B | 39.54% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Liaoning Chengda Biotechnology | 8.53B |
| Beijing Hotgen Biotech | 8.34B |
| Aurisco Pharmaceutical | 8.02B |
| Innovita Biological Technology | 7.78B |
| Chengdu Easton Biopharmaceuticals | 7.67B |
| Daan Gene | 7.66B |
| Bio-Thera Solutions | 7.54B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 7.41B |